Mather Group LLC. Increases Position in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Share on StockTwits

Mather Group LLC. lifted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 18.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,122 shares of the pharmacy operator’s stock after purchasing an additional 13,010 shares during the period. Mather Group LLC.’s holdings in Walgreens Boots Alliance were worth $4,708,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Taylor Hoffman Wealth Management boosted its holdings in shares of Walgreens Boots Alliance by 360.0% during the 3rd quarter. Taylor Hoffman Wealth Management now owns 460 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 360 shares during the last quarter. Sageworth Trust Co bought a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at about $27,000. Quest Capital Management Inc. ADV bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $31,000. First Interstate Bank lifted its holdings in shares of Walgreens Boots Alliance by 228.1% in the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 422 shares during the last quarter. Finally, TRUE Private Wealth Advisors bought a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at about $38,000. Hedge funds and other institutional investors own 60.10% of the company’s stock.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $63.16, for a total value of $14,801,861.80. Following the completion of the sale, the chief accounting officer now directly owns 13,844 shares in the company, valued at $874,387.04. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 15.73% of the stock is owned by company insiders.

Shares of NASDAQ:WBA traded down $0.08 during trading on Wednesday, reaching $58.91. 3,765,302 shares of the company were exchanged, compared to its average volume of 5,861,608. The firm has a market capitalization of $53.20 billion, a PE ratio of 9.83, a P/E/G ratio of 1.49 and a beta of 0.88. The business’s fifty day simple moving average is $58.39 and its 200-day simple moving average is $54.41. Walgreens Boots Alliance Inc has a 12-month low of $49.03 and a 12-month high of $83.57. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.73 and a quick ratio of 0.36.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Monday, October 28th. The pharmacy operator reported $1.43 EPS for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.02. The business had revenue of $33.95 billion for the quarter, compared to analyst estimates of $33.88 billion. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $1.48 earnings per share. On average, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.93 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a $0.458 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.83 annualized dividend and a yield of 3.11%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.55%.

WBA has been the subject of a number of analyst reports. Pivotal Research lowered their price target on shares of Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating for the company in a report on Wednesday, October 30th. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a report on Friday, August 23rd. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating for the company in a report on Thursday, October 3rd. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada downgraded shares of Walgreens Boots Alliance to a “hold” rating and set a $59.00 price target for the company. in a report on Friday, September 27th. Five research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $61.35.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Roth IRA

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.